The company is pulling eight product types, including 175,000 units of tubing, 32,000 IV administration sets and 24,400 fluid transfer sets. The reason for the recall is because of a potential leaking issue, which can lead to a delay in therapy, increased risk of bloodstream infection and exposure risk of hazardous drugs.
“There is also the potential for life-threatening situations to occur requiring additional medical intervention,” the FDA post said. The database does not report adverse events.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
